The regional pharmaceutical landscape is changing
The pharmaceutical industry in Central America is undergoing a full evolution. 2025 will be a key year for the development of new products, stricter regulations, and growing demand for more accessible and effective medications. At FG Pharma, we analyze the most important changes shaping the direction of the sector.
1. Increased demand for certified generics
The optimization of public budgets has led to a preference for generic medications backed by bioequivalence studies. This opens opportunities for laboratories that offer quality at competitive prices.
2. Growing interest in natural products and supplements
Consumers are increasingly informed and seeking preventive and complementary alternatives. Product lines that combine natural ingredients with therapeutic benefits are rapidly gaining ground in the private segment.
3. Expansion of international laboratories in the region
Laboratories from India, Colombia, and the Dominican Republic are increasing their presence in Central America through strategic alliances with local distributors such as FG Pharma. This allows them to adapt to local regulations and participate in bidding processes.
4. Greater regulatory requirements and the need for certifications
The National Directorate of Medicines (DNM) and other Central American entities are tightening requirements, making technical backing (FDA, EMA, INVIMA) mandatory for products to enter the market.
FG Pharma is ready
At FG Pharma International, we represent forward-thinking laboratories and facilitate their expansion in the region with advisory services, distribution, and strategic positioning.
Are you a laboratory interested in Central America?
💼 Contact us to evaluate a partnership: contacto@fgpharmasv.com
